World's Best Scientists 2026 revealed!
Pierfrancesco Tassone

Pierfrancesco Tassone

D-Index & Metrics

Medicine

D-Index
86
Citations
22372
World Ranking
14293
National Ranking
548

Overview

Pierfrancesco Tassone is affiliated with Magna Graecia University in Italy. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Molecular Biology and Oncology. The scientist's work encompasses various subfields including Cancer Research, Immunology, and Pulmonary and Respiratory Medicine.

The main topics of their research include:

  • Cancer Immunotherapy and Biomarkers
  • Cancer-related molecular mechanisms research
  • Multiple Myeloma Research and Treatments
  • CAR-T cell therapy research
  • MicroRNA in disease regulation
  • RNA Research and Splicing
  • RNA Interference and Gene Delivery

Among recent papers published with their involvement are:

  • "Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter"" (2020), published in Journal of Experimental & Clinical Cancer Research
  • "Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial" (2020), published in The Lancet Respiratory Medicine
  • "miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review" (2022), published in Molecular Therapy - Nucleic Acids
  • "Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease" (2020), published in Scientific Reports
  • "Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel" (2021), published in Cancers

The scientist has published frequently in several academic venues, including:

  • Cancers
  • Blood
  • Journal of Experimental & Clinical Cancer Research
  • Molecular Therapy - Nucleic Acids
  • Journal of Clinical Oncology

Collaboration has been an important aspect of their work, especially with frequent co-authors including:

  • Maria Teresa Di Martino
  • Daniele Caracciolo
  • Pierosandro Tagliaferri
  • Mariamena Arbitrio
  • Francesca Scionti

Best Publications

  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

    Miguel Martin;Frankie A Holmes;Bent Ejlertsen;Suzette Delaloge

  • Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

    Arlene Chan;Suzette Delaloge;Frankie A Holmes;Beverly Moy

  • Mir-34: A New Weapon Against Cancer?

    Gabriella Misso;Maria Teresa Di Martino;Giuseppe De Rosa;Ammad Ahmad Farooqi

  • Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma

    Mariateresa Fulciniti;Pierfrancesco Tassone;Teru Hideshima;Sonia Vallet

  • BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

    P Tassone;P Tassone;P Tagliaferri;A Perricelli;S Blotta

  • HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

    Ennio Carbone;Paola Neri;Maria Mesuraca;Mariateresa T. Fulciniti

  • Aggresome induction by proteasome inhibitor bortezomib and α-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells

    Laurence Catley;Ellen Weisberg;Ellen Weisberg;Tanyel Kiziltepe;Tanyel Kiziltepe;Yu-Tzu Tai;Yu-Tzu Tai

  • Dysfunctional T regulatory cells in multiple myeloma

    Rao H. Prabhala;Paola Neri;Jooeun E. Bae;Pierfrancesco Tassone

  • MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.

    Nicola Amodio;Lavinia Raimondi;Giada Juli;Maria Angelica Stamato

  • Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence

    Maria T. Di Martino;Emanuela Leone;Nicola Amodio;Umberto Foresta

  • Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

    Pierpaolo Correale;Maria Saveria Rotundo;Maria Teresa Del Vecchio;Cinzia Remondo

  • Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth

    Emanuela Leone;Eugenio Morelli;Maria T. Di Martino;Nicola Amodio

  • Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.

    Yi-Long Wu;Ying Cheng;Jianying Zhou;Shun Lu

  • Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.

    Nicola Amodio;Maria Angelica Stamato;Giada Juli;Eugenio Morelli

  • miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease.

    Marco Rossi;Maria Rita Pitari;Nicola Amodio;Maria Teresa Di Martino

  • Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines.

    P Tassone;S Forciniti;E Galea;G Morrone

  • Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.

    P Tassone;P Tagliaferri;C Viscomi;C Palmieri

  • miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

    N Amodio;M T Di Martino;U Foresta;E Leone

  • Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.

    Pierfrancesco Tassone;Victor S. Goldmacher;Paola Neri;Antonella Gozzini

  • B563 Anti-DKK1 mAb (BHQ880) as a Potential Therapeutic Agent for Multiple Myeloma

    M Fulciniti;S Vallet;S Ettenberg;X Shen

Frequent Co-Authors

Nikhil C. Munshi
Nikhil C. Munshi Harvard University
Salvatore Venuta
Salvatore Venuta Magna Graecia University
Antonino Neri
Antonino Neri University of Milan
Michele Caraglia
Michele Caraglia University of Campania "Luigi Vanvitelli"
Kenneth C. Anderson
Kenneth C. Anderson Harvard University
Teru Hideshima
Teru Hideshima Harvard University
Dharminder Chauhan
Dharminder Chauhan Harvard University
Yu-Tzu Tai
Yu-Tzu Tai Harvard University
Luca Agnelli
Luca Agnelli University of Milan
Mario Cannataro
Mario Cannataro Magna Graecia University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees offers flexible options for advancing your career in medicine, healthcare, or administration. Many students aiming for medical professions consider accelerated msn psychiatric np programs to quickly transition into high-demand mental health nurse practitioner roles. These programs often provide intensive coursework with the convenience of online learning.

For those interested in non-clinical healthcare careers, a healthcare administration degree cost is a key factor to weigh. Comparing tuition rates and scholarship opportunities is essential, as costs can vary widely between institutions.

Aspiring leaders can also look for the cheapest online mha programs to earn a Master’s in Healthcare Administration without accumulating significant debt. Budget-friendly options make it possible to access high-quality education and unlock leadership roles in hospitals, clinics, or health systems.

Finally, nurses aiming for advanced practice can seek the least expensive dnp programs to achieve a Doctor of Nursing Practice degree online. Affordable online DNP programs help professionals reach the highest level of nursing expertise while maintaining their current jobs.

Best Scientists Citing Pierfrancesco Tassone

Trending Scientists